SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jay silberman who wrote (112)12/9/1996 3:01:00 AM
From: T. Mann   of 6136
 
Jay,

i think AGPH is a perfect short at this price (if not now then after HQ Conference in January). They may see some earnings in the late 97 and (may be) some real profits in early 99. The protease inhibitors are terribly expensive to make (Merk is currently loosing money). The AIDS market may look very different 2 years from now. Let's be realistic! I have seen too many biotech stocks coming crushing down when they approached approval/marketing time. There will be time in 97 to pick up AGPH in the $30-40 range.

T.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News